Objections to publication Sample Clauses

Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Participant’s Background, Foreground or other Confidential Information; or the objecting Participant’s legitimate academic or commercial interests are harmed by the publication; the proposed publication includes patentable Foreground and the objecting Participant anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Participants involved shall discuss a solution in good faith. The objecting Participant can request a publication delay of an additional period of 150 (hundred fifty) calendar days (following the 30 (thirty) day period referred to in Section 8.9). Upon expiration of the term, the publishing Participant will be entitled to publish the proposed publication, provided that Confidential Information of the objecting Participant has been removed from the publication as indicated by the objecting Participant. Use of names, logos or trademarks. Nothing in this Consortium Agreement shall be construed as conferring rights to use in advertising, publicity or otherwise the name of the Participants or any of their logos or trademarks without their prior written approval.
Sample 1Sample 2Sample 3See All (21)
AutoNDA by SimpleDocs
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Party’s Background, Foreground or other Confidential Information; or the proposed publication includes patentable Foreground and the objecting Party anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Parties involved shall discuss a solution in good faith. Within the time limits stated in Article 8.9, the objecting Party may request removal of its Background, Foreground or other Confidential Information, or, if the objection is based on (b) above, a publication delay of at most 60 (sixty) calendar days, in which event the intended publication will be delayed to allow a patent application to be filed. Upon expiration of the term, the publishing Party will be entitled to publish the proposed publication. The Parties acknowledge that if the Project consists of the performance of clinical research that is subject to the Dutch Medical Research Involving Human Subjects Act (WMO), publication arrangements under Sections 8.9 and 8.10 are subject to the Revised CCMO Directive on the Assessment of Clinical Trial Agreements of 30 August 2011, and that in case of any conflict, the latter shall prevail.
Sample 1Sample 2Sample 3See All (8)
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Party’s Background, Foreground or other Confidential Information; or the objecting Party’s legitimate academic or commercial interests are harmed by the publication; the proposed publication includes patentable Foreground and the objecting Party anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Parties involved shall discuss a solution in good faith. The objecting Party can request a publication delay of at most 90 (ninety) calendar days, unless the objection is based on (b) or (c) above, in which event the intended publication can be delayed for up to six (6) months to allow a patent application to be filed. Upon expiration of the term, the publishing Party will be entitled to publish the proposed publication.
Sample 1Sample 2Sample 3See All (6)
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Participant’s Background, Foreground or other Confidential Information; or the objecting Participant’s legitimate academic or commercial interests are harmed by the publication; the proposed publication includes patentable Foreground and the objecting Participant anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Participants involved shall discuss a solution in good faith. The objecting Participant can request a publication delay of an additional period of 150 (hundred fifty) calendar days (following the 30 (thirty) day period referred to in Section 8.9). Upon expiration of the term, the publishing Participant will be entitled to publish the proposed publication, provided that Confidential Information of the objecting Participant has been removed from the publication as indicated by the objecting Participant.
Sample 1Sample 2Sample 3
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Partner’s Background, Foreground or other Confidential Information; or the objecting Partner’s legitimate academic or commercial interests are harmed by the publication; the proposed publication includes patentable Foreground and the objecting Partner anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Partners involved shall discuss a solution in good faith. The objecting Partner can request a publication delay of an additional period of 60 (sixty) calendar days (following the 30 (thirty) day period referred to in Section 5.9). Upon expiration of the term, the publishing Partner will be entitled to publish the proposed publication, provided that Confidential Information of the objecting Partner has been removed from the publication as indicated by the objecting Partner. Use of names, logos or trademarks. Nothing in this Consortium Project Agreement shall be construed as conferring rights to use in advertising, publicity or otherwise the name of the Partners or any of their logos or trademarks without their prior written approval.
Sample 1Sample 2Sample 3
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Party’s Background, Foreground or other Confidential Information; or the objecting Party’s legitimate academic or commercial interests are harmed by the publication; the proposed publication includes patentable Foreground and the objecting Party anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Parties involved shall discuss a solution in good faith. The objecting Party can request a publication delay of an additional period of 60 (sixty) calendar days (following the 30 (thirty) day period referred to in Section 8.9). Upon expiration of the term, the publishing Party will be entitled to publish the proposed publication.
Sample 1Sample 2Sample 3
Objections to publication. (a) Either Party may object to the University’s proposed presentation or proposed publication on the grounds that: (i) it contains Confidential Information that was disclosed to the University by Hana or INEX; or (ii) it discloses patentable subject matter which needs protection. (b) If either Party makes an objection under Section 9.3(a)(i), the Party so objecting shall specify the portions of the presentation or publication considered objectionable (the “Objectionable Material”). INEX shall forward all objections to the University within four (4) days of issuing or receiving an objection. Upon receipt of notification from Hana that any proposed publication or disclosure contains Objectionable Material, the University and INEX shall work together to revise the proposed publication or presentation to remove or alter the Objectionable Material in a manner acceptable to Hana, in which case Hana shall withdraw its objection. INEX shall co-operate in all reasonable respects in making revisions to any proposed disclosures if considered by Hana to contain Objectionable Material. Hana acknowledges that the University shall not be restricted from publishing or presenting the proposed disclosure as long as the Objectionable Material has been removed. In respect of any disclosures by the University pursuant to Section 9.7 of the UBC License, upon Hana’s request, INEX shall request that Hana’s Confidential Information shall be deleted therefrom prior to disclosure by the University. (c) If Hana makes an objection under Section 9.3(a)(i), thereafter Hana and/or INEX may file a patent application and the Parties acknowledge that the University is obligated under the UBC License to ensure that its researchers refrain from making such publication or presentation until one or more patent applications have been filed with one or more patent offices directed to such patentable subject matter, or until three (3) months have elapsed from date of receipt of the written objection by the University, whichever is sooner, after which the University and its researchers may proceed with said presentation or publication. For greater certainty, a provisional patent application shall be considered to be a patent application in the United States of America for the purposes of this Agreement.
Sample 1
AutoNDA by SimpleDocs
Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: a. the proposed publication includes another Party’s Background, Foreground or other Confidential Information; or b. the objecting Party’s legitimate academic or commercial interests are harmed by the publication; Opmerking [L5]: Partijen mogen van deze termijnen afwijken tenzij het Project (gedeeltelijk) betrekking heeft op een klinische studie waarvoor toestemming dient xx xxxxxx verkregen van een METC / CCMO in overeenstemming met de CCMO-richtlijn Beoordeling onderzoekscontracten. c. the proposed publication includes patentable Foreground and the objecting Party anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Parties involved shall discuss a solution in good faith. The objecting Party can request a publication delay of an additional period of 60 (sixty) calendar days (following the 30 (thirty) day period referred to in Section 8.9). Upon expiration of the term, the publishing Party will be entitled to publish the proposed publication.
Sample 1

Related to Objections to publication

  • Root-­‐zone Information Publication ICANN’s publication of root-­‐zone contact information for the TLD will include Registry Operator and its administrative and technical contacts. Any request to modify the contact information for the Registry Operator must be made in the format specified from time to time by ICANN at xxxx://xxx.xxxx.xxx/domains/root/.

  • Access to Public Records No records of District shall be made available for public inspection or copying by NWRDC, NWESD, or XXXXX without express written authorization of District. Requests pursuant to RCW 42.17 for inspection or copying of public records of District, held or maintained by NWRDC shall be referred to District.

  • Publications Neither Party shall publicly present or publish results of studies carried out under this Agreement (each such presentation or publication a “Publication”) without the opportunity for prior review by the other Party, except to the extent otherwise required by Applicable Law, in which case Section 12.3 shall apply with respect to disclosures required by the SEC and/or for regulatory filings. The submitting Party shall provide the other Party the opportunity to review any proposed Publication at least thirty (30) days prior to the earlier of its presentation or intended submission for publication. The submitting Party agrees, upon request by the other Party, not to submit or present any Publication until the other Party has had thirty (30) days to comment on any material in such Publication. The submitting Party shall consider the comments of the other Party in good faith, but will retain the sole authority to submit the manuscript for Publication; provided that the submitting Party agrees to delay such Publication as necessary to enable the Parties to file a Patent if such Publication might adversely affect such Patent. The submitting Party shall provide the other Party a copy of the Publication at the time of the submission or presentation. Notwithstanding the foregoing, BMS shall not have the right to publish or present Ambrx’s Confidential Information without Ambrx’s prior written consent, and Ambrx shall not have the right to publish or present BMS’ Confidential Information without BMS’ prior written consent. Each Party agrees to acknowledge the contributions of the other Party, and the employees of the other Party, in all publications as scientifically appropriate. This Section 12.4 shall not limit and shall be subject to Section 12.5. Nothing contained in this Section 12.4 shall prohibit the inclusion of information in a patent application claiming, and in furtherance of, the manufacture, use, sale or formulation of a Compound, provided that the non-filing Party is given a reasonable opportunity to review, comment upon and/or approve the information to be included prior to submission of such patent application, where and to the extent required by Article 9 hereof. Notwithstanding the foregoing, the Parties recognize that independent investigators have been engaged, and will be engaged in the future, to conduct Clinical Trials of Compounds and Products. The Parties recognize that such investigators operate in an academic environment and may release information regarding such studies in a manner consistent with academic standards; provided that each Party will use reasonable efforts to prevent publication prior to the filing of relevant patent applications and to ensure that no Confidential Information of either Party is disclosed.

  • Right to Publish Throughout the duration of this Master Agreement, Contractor must secure from the Lead State prior approval for the release of information that pertains to the potential work or activities covered by the Master Agreement. This limitation does not preclude publication about the award of the Master Agreement or marketing activities consistent with any proposed and accepted marketing plan. The Contractor shall not make any representations of NASPO ValuePoint’s opinion or position as to the quality or effectiveness of the services that are the subject of this Master Agreement without prior written consent. Failure to adhere to this requirement may result in termination of the Master Agreement for cause.

  • RELEASE OF GENERAL INFORMATION TO THE PUBLIC AND MEDIA NASA or Partner may, consistent with Federal law and this Agreement, release general information regarding its own participation in this Agreement as desired. Pursuant to Section 841(d) of the NASA Transition Authorization Act of 2017, Public Law 115-10 (the "NTAA"), NASA is obligated to publicly disclose copies of all agreements conducted pursuant to NASA's 51 U.S.C. §20113(e) authority in a searchable format on the NASA website within 60 days after the agreement is signed by the Parties. The Parties acknowledge that a copy of this Agreement will be disclosed, without redactions, in accordance with the NTAA.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!